elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40987678-4D28327C-C9C5-4B18-81AB-91EAC4200FFB
Q40987678-4D28327C-C9C5-4B18-81AB-91EAC4200FFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40987678-4D28327C-C9C5-4B18-81AB-91EAC4200FFB
MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells
P2860
Q40987678-4D28327C-C9C5-4B18-81AB-91EAC4200FFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40987678-4D28327C-C9C5-4B18-81AB-91EAC4200FFB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d47c0fdfbc848d0cbe321b9f0b61bd65d66e8f7f
P2860
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit.